An expert explains the unique dosing considerations for emicizumab compared to factor VIII in hemophilia A, covering prophylaxis and breakthrough bleeding scenarios. This is a video synopsis/summary ...

Hemab Therapeutics, a late stage clinical biotechnology company developing novel prophylactic therapeutics for serious, underserved coagulation disorders, today announced that the U.S. Food and Drug ...

Annovera (segesterone acetate and ethinyl estradiol) is a prescription drug used to prevent pregnancy. Annovera can cause side effects that range from mild to serious. Examples include breakthrough ...

Sutacimig is an investigational bispecific antibody designed to bind to endogenous factor VIIa and localize it to activated platelets, thereby promoting thrombin and fibrin formation.

Studies on vaccines rarely consider menstruation as a variable and focus on how vaccines affect fertility or pregnant women. A U.S. Vaccine Adverse Event Reporting System (VAERS) study found that ...